Cachexia is a paraneoplastic syndrome of unintentional adipose and muscle tissue wasting with severe impacts to functionality and quality of life. Although health inequities across minority and ...

New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...

About one third of cancer patients die because of cachexia - an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...

According to the National Cancer Institute, nearly one-third of cancer deaths can be attributed to a wasting syndrome known as cachexia. Cachexia, an indicator of the advanced stages of disease, is a ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...

One of the most pernicious conditions that arises as a consequence of cancer is a sort of wasting syndrome. More formally known as cachexia, it causes patients to lose body mass (including both muscle ...

It is estimated that as many as 80% of advanced-stage cancer patients may develop cachexia, a potentially fatal metabolic syndrome characterized by extreme weight loss and muscle wasting, but ...

Mealtimes were always a family affair for the Kochanczyks of Indiana. Dave Kochanczyk loved barbecuing, cooking Polish fare and preparing fresh vegetables from the garden. When not in the kitchen, he ...

Cachexia—a syndrome characterized by progressive muscle wasting—affects both humans and dogs with chronic diseases such as ...

Curanex Pharmaceuticals Inc. CURX on Wednesday highlighted five additional patient cases that management believes further support the potential of its lead candidate, Phyto-N, in cancer cachexia. The ...